Schizophrenia Research
Volume 123, Issue 2 , Pages 276-277 , November 2010

A head-to-head comparison of sertindole and risperidone on metabolic parameters

  • Marc De Hert

      Affiliations

    • University Psychiatric Center Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium
    • Corresponding Author InformationCorresponding author. UPC KUL campus Kortenberg, Leuvensesteenweg 517, 3070 Kortenberg, Belgium. Tel.: +32 2 758 05 11; fax: +32 2 759 98 78.
    • ,
  • Aurélia Mittoux

      Affiliations

    • H. Lundbeck A/S, Ottiliavej 9, Valby, Copenhagen, Denmark
    • ,
  • Yuan He

      Affiliations

    • H. Lundbeck A/S, Ottiliavej 9, Valby, Copenhagen, Denmark
    • ,
  • Joseph Peuskens

      Affiliations

    • University Psychiatric Center Catholic University Leuven, Leuvensesteenweg 517, 3070 Kortenberg, Belgium

Received 29 March 2010 ,Revised 19 July 2010 ,Accepted 27 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Clinical trial registration: Safety study of sertindole versus risperidone under normal conditions of use. NCT 00856583 (EudraCT 2004-000213-19). http://clinicaltrials.gov/ct2/results?term=00856583.

PII: S0920-9964(10)01446-5

doi: 10.1016/j.schres.2010.07.030

Schizophrenia Research
Volume 123, Issue 2 , Pages 276-277 , November 2010

Article Tools

* Image Usage & Resolution